// App-Quantinova.ai

2892 : FOXD3 is a novel repressor of the expression of short isoform of DCLK1 (DCLK1-S) from IntronV()-promoter of hDCLK1-gene, and is epigenetically silenced in hCRCs: prognostic/diagnostic implications of FOXD3/DCLK1-S expression in hCRCs

Researchers

Presenter

  • Malaney R. OConnell

Principal Investigators

  • Shubhashish Sarkar

  • Gurinder Luthra

  • Yoshinaga Okugawa

  • Yuji Toiyama

  • Denise Ward

  • Ajay Goel

  • Pomila Singh

Medical Centers

  • The University of Texas Medical Branch, Galveston, TX

  • Baylor University Medical Center, Dallas, TX

  • Mie University, Mie, Japan

Locations

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Pancreatic cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved